Brief Profile

Diss Brief Profile

The Brief Profile summarizes the non-confidential data on substances as it is held in the databases of the European Chemicals Agency (ECHA), including data provided by third parties. The Brief Profile is automatically generated; note that it does not currently distinguish between harmonised classification and minimum classification; information requirements under different legislative frameworks may therefore not be fully up to date or complete. For accuracy reasons, substance manufacturers and imports have the responsibility to consult official sources, e.g. the electronic edition of the Official Journal of the European Union.
This Brief Profile is covered by the ECHA Legal Notice.

Substance Description

Substance identity

  • EC / List name:
  • IUPAC name: nickel(2+) tetrasodium 33-({3-[(1E)-2-(1-{3-[(4,6-dichloro-5-cyanopyrimidin-2-yl)(methyl)amino]propyl}-2-hydroxy-4-methyl-6-oxo-1,6-dihydropyridin-3-yl)diazen-1-yl]-4-sulfonatophenyl}sulfamoyl)-2,11,20,29,37,38,39,40-octaazanonacyclo[28.6.1.1³,¹⁰.1¹²,¹⁹.1²¹,²⁸.0⁴,⁹.0¹³,¹⁸.0²²,²⁷.0³¹,³⁶]tetraconta-1(36),2,4(9),5,7,10(40),11,13(18),14,16,19,21(38),22(27),23,25,28,30,32,34-nonadecaene-37,39-diide-7,15,24-trisulfonate
  • Substance names and other identifiers
EC / List no.:
410-160-7
CAS no.:
148732-74-5
Index number:
607-288-00-2
Molecular formula:
C53H30Cl2N16Na4NiO16S5
SMILES:
[Na+].[Na+].[Na+].[Na+].[Ni++].CN(CCCN1C(=O)C=C(C)C(\N=N\C2=CC(NS(=O)(=O)C3=CC4=C5[N-]C(\N=C6/N=C(/N=C7\[N-]\C(=N/C8=N/C(=N\5)/C5=C8C=C(C=C5)S([O-])(=O)=O)C5=C7C=C(C=C5)S([O-])(=O)=O)C5=C6C=CC(=C5)S([O-])(=O)=O)=C4C=C3)=CC=C2S([O-])(=O)=O)=C1O)C1=NC(Cl)=C(C#N)C(Cl)=N1
InChI:
InChI=1S/C53H35Cl2N16O16S5.4Na.Ni/c1-23-16-40(72)71(15-3-14-70(2)53-57-42(54)37(22-56)43(55)58-53)52(73)41(23)68-67-38-17-24(4-13-39(38)92(85,86)87)69-88(74,75)25-5-9-29-33(18-25)48-60-44(29)59-45-30-10-6-27(90(79,80)81)20-35(30)50(61-45)66-51-36-21-28(91(82,83)84)8-12-32(36)47(65-51)64-49-34-19-26(89(76,77)78)7-11-31(34)46(62-48)63-49;;;;;/h4-13,16-21,69H,3,14-15H2,1-2H3,(H6-,59,60,61,62,63,64,65,66,67,68,72,73,76,77,78,79,80,81,82,83,84,85,86,87);;;;;/q-1;4*+1;+2/p-5
Type of substance:
Origin:
Registered compositions:
1
Of which contain:
0 impurities relevant for classification
0 additives relevant for classification
Substance Listed:
ELINCS (European LIst of Notified Chemical Substances) List

Hazard classification & labelling

Warning! According to the harmonised classification and labelling (CLP00) approved by the European Union, this substance causes serious eye irritation, is harmful to aquatic life with long lasting effects and may cause an allergic skin reaction.

Breakdown of all 37 C&L notifications submitted to ECHA

Eye Irrit. 2 H319 Harmonised Classification
Aquatic Chronic 3 H412 Harmonised Classification
Skin Sens. 1 H317 Harmonised Classification
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

https://chesar.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/tick.png Harmonised Classification

https://chesar.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/Reach.png REACH registration dossiers notifications

https://chesar.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/CLP.png CLP notifications

Properties of concern

  • Ss
Officially recognised in the EU as Skin sensitising ( Harmonised C&L).
  • Ss
There is broad agreement in that a majority of data submitters agree this substance is Skin sensitising (100% of CLP notifications).

Regulatory context

Registration, Evaluation, Authorisation & Restriction of Chemicals (REACH)

Registration
Pre-registration:
Substance pre-registered under REACH.
Registration:
This substance has 2 active registrations under REACH, 1 Joint Submission(s) and 0 Individual Submission(s).
Please see Registrants/Suppliers details.
Evaluation
Dossier Evaluation:
Substance Evaluation:
Authorisation
Candidate List:
Annex XIV (Authorisation List):
Restriction
Annex XVII (Restriction List):
Some uses of this substance are restricted under Annex XVII of REACH.

Persistent Organic Pollutants Regulation (POPs)

List of substances subject to the POPs Regulation:
List of substances proposed as POPs:

Classification Labelling & Packaging (CLP)

Harmonised C&L:
A European Union Harmonised Classification & Labelling has been assigned to this substance.
Seveso Annex I:
Notified C&L:
Classification & Labelling has been notified by industry to ECHA for this substance.

Biocidal Products Regulation (BPR)

Active Substance:
Biocidal Products:

Prior Informed Consent (PIC)

Annex I:
Annex V:

European Union Observatory for Nanomaterials (EUON)

EUON:

About this substance

This substance is registered under the REACH Regulation and is manufactured in and / or imported to the European Economic Area, but the tonnage data is confidential.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data indicating whether or into which articles the substance might have been processed.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the types of manufacture using this substance.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the types of manufacture using this substance.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no data from registration dossiers on the precautionary measures for using this substance. Guidance on the safe use of the substance provided by manufacturers and importers of this substance.

Registrants/suppliers

  • Archroma Germany GmbH, Kasteler Str. 45 65203 Wiesbaden Germany
  • ARCHROMA IBÉRICA, S.L., ZAL-Prat c/Cal Coracero, 46-56 08820 El Prat de Llobregat Spain
  • Archroma Italy, S.r.l., Via Manzoni 37 20030 Palazzolo Milanese Italy
  • Archroma UK, Ltd, 1 Bartholomew Lane EC2N 2AX London United Kingdom
  • Former NONS notifier unknown to ECHA - Contact the relevant Belgian competent national authority., null
  • Former NONS notifier unknown to ECHA - Contact the relevant Dutch competent national authority., null
  • Former NONS notifier unknown to ECHA - Contact the relevant French competent national authority., null
  • Former NONS notifier unknown to ECHA - Contact the relevant Portuguese competent national authority., null

Substance names and other identifiers

BRILLIANT GREEN K-RWA 6083
BRILLANTGREEN K-RWA 6083; BRILLIANT GREEN K-RWA 6083
Other
tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a, b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively
BRILLANTGREEN K-RWA 6083; BRILLIANT GREEN K-RWA 6083
Other, CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, End-of-Life Vehicles Directive - Hazardous Substances, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, Medical Devices Regulation - Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties, Physical, Biological and Chemical Agents & Processes and Work
Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively
BRILLANTGREEN K-RWA 6083; BRILLIANT GREEN K-RWA 6083
C&L Inventory
Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4and 2 respectively
EC Inventory, REACH pre-registration
Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4and 2 respectively
BRILLANTGREEN K-RWA 6083; BRILLIANT GREEN K-RWA 6083
REACH pre-registration, Other
(c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(méthyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-méthyl-6-oxo-3-pyridylazo)-4-sulfonatophénylsulfamoyl)phtalocyanine-a, b,d-trisulfonato(6-))nickelate II de tétrasodium, où a = 1, 2, 3 ou 4, b = 8, 9, 10 ou 11, c = 15, 16, 17 ou 18, d = 22, 23, 24 ou 25, et où e et f ensemble sont respectivement égaux à 2 et 4 ou à 4 et 2 (fr)
C&L Inventory
(c-(3-(1-(3-(e-6-dicloro-5-cianopirimidin-f-il(metil)ammino)propil)-1,6-diidro-2-idrossi-4-metil-6-osso-3-piridilazo)-4-solfonatofenilsolfamoil)ftalocianin-a,b,d-trisolfonato(6-))nichelato II di tetrasodio, dove a è 1 o 2 o 3 o 4,b è 8 o 9 o 10 o 11, c è 15 o 16 o 17 o 18, d è 22 o 23 o 24 o 25 e dove e ed f insieme sono 2 e 4 o 4 e 2 rispettivamente (it)
C&L Inventory
(c-(3-(1-(3-(e-6-dicloro-5-cianopirimidina-f-il(metil)amino)propil)-1,6-dihidro-2-hidroxi-4-metil-6-oxo-3-piridilazo)-4-sulfonatofenilsulfamoil)ftalocianina-a,b,d-trissulfonato(6-))níquelato II de tetrasssódio, aonde a é 1 ou 2 ou 3 ou 4,b é 8 ou 9 ou 10 ou 11, c é 15 ou 16 ou 17 ou 18, d é 22 ou 23 ou 24 ou 25 e aonde e e f são 2 e 4 ou 4 e 2 respectivamente (pt)
C&L Inventory
(c-(3-(1-(3-(e-6-dicloro-5-cianopirimidín-f-il(metil)amino)propil)-1,6-dihidro-2-hidroxi-4-metil-6-oxo-3-piridilazo)-4-sulfonatofenilsulfamoil)ftalocianin-a,b,d-trisulfonato(6-))niquelato II de tetrasodio, donde a es 1 ó 2 ó 3 ó 4,b es 8 ó9 ó 10 ó 11, c es 15 ó 16 ó 17 ó 18, d es 22 ó 23 ó 24 ó 25 y donde e y f aparecen simultáneamente, son 2 y 4 ó 4 y 2 respectivamente (es)
C&L Inventory
(c-(3-(1-(3-(e-6-διχλωρo-5-κυανoπυριμιδινo-f-υλo(μεθυλo)αμινo)πρoπυλo)-1,6-διυδρo-2-υδρoξυ-4-μεθυλo-6-oξo-3-πυριδυλαζω)-4-σoυλφoνικoφαινυλoσoυλφαμoϋλo)φθαλoκυανινo-a,b,d-τρισoυλφoνικό(6-))νικελικό II τετρανάτριo, όπoυ a είναι 1 ή 2 ή 3 ή 4 b είναι 8 ή 9 ή 10 ή 11, c είναι 15 ή 16 ή 17 ή 18, d είναι 22 ή 23 ή 24 ή 25 και όπoυ e και f μαζί είναι 2 και 4 ή 4 και 2 αντιστoίχως (el)
C&L Inventory
[c(N-{3-[(1-{3-[(2,6(4,6)-dichlor-5-kyanpyrimidin-4(2)-yl)methylamino]propyl}-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-3-pyridyl)azo]-4-sulfonatofenyl}sulfamoyl)- a,b,d-trisulfonatoftalocyanin]nikelnatý komplex, tetrasodná sůl a=1,2,3 nebo 4, b=8,9,10 nebo 11, c=15,16,17 nebo 18, d=22,23,24 nebo 25 (cs)
C&L Inventory
[c-(N-{3-[(1-{3-[(e,6-dichlór-5-kyanopyrimidín-f-yl)(metyl)amino]propyl}-2-hydroxy-4-metyl-6-oxo-1,6-dihydro-3-pyridyl)diazenyl]-4-sulfonátofenyl}sulfamoyl)-a,b,d-trisulfonátoftalocyanín]nikelnatan tetrasodný, kde a je 1, 2, 3 alebo 4; b je 8, 9, 10 alebo 11; c je 15, 16, 17 alebo 18; d je 22, 23, 24 alebo 25 a kde e je 2 a zároveň f je 4 alebo e je 2 a zároveň f je 4 (sk)
C&L Inventory
tetranaatrium(c-(3-(1-(3-(e-6-dikloro-5-tsüanopürimidiin-f-üül(metüül)amino)propüül)-1,6-dihüdro-2-hüdroksü-4-metüül-6-okso-3-püridüülaso)-4-sulfonatofenüülsulfamoüül)ftalotsüaniin-a,b,d-trisulfonato(6-))nikelaat (II), kus a on 1 või 2 või 3 või 4, b on 8 või 9 või 10 või 11, c on 15 või 16 või 17 või 18, d on 22 või 23 või 24 või 25 ja kus e ja f kokku on vastavalt 2 ja 4 või 4 ja 2 (et)
C&L Inventory
Tetranatrijev (c-(3-(1-(3-(e-6-dikloro-5-cianopirimidin-f-il(metil)amino)propil)-1,6-dihidro-2-hidroksi-4-metil-6-okso-3-piridilazo)-4-sulfonatofenilsulfamoil)ftalocianin-a,b,d-trisulfonato(6-))nickelid(II), gdje a = 1 ili 2 ili 3 ili 4, b = 8 ili 9 ili 10 ili 11, c = 15 ili 16 ili 17 ili 18, d = 22 ili 23 ili 24 ili 25 i gdje su e i f zajedno = 2 i 4 odnosno 4 i 2 (hr)
C&L Inventory
tetranatrijev c-[3-(1-{3-[e-6-dikloro-5-cianopirimidin-f-il(metil)amino]propil}-1,6-dihidro-2-hidroksi-4-metil-6-okso-3-piridilazo)-4-sulfonatofenilsulfamoil]ftalocianin-a,b,d-trisulfonato(6-)niklat(II), kjer je a=1 ali 2 ali 3 ali 4,b=8 ali 9 ali 10 ali 11,c=15 ali 16 ali 17 ali 18,d=22 ali 23 ali 24 ali 25 in kjer sta e=2 in f=4 ali e=4 in f=2 (sl)
C&L Inventory
tetranatrio (c-(3-(1-(3-(e-6-dichlor-5-cianpirimidin-f-il(metil)amino)propil)-1,6-dihidro-2-hidroksi-4-metil-6-okso-3-piridilazo)-4-sulfonatofenilsulfamoil)ftalocianin-a,b,dtrisulfonato(6-)) nikelatas II, kai a yra 1 arba 2, arba 3, arba 4, b yra 8 arba 9, arba 10, arba 11, c yra arba 15, arba 16, arba 17, arba 18, d yra arba 22, arba 23, arba 24, arba 25 ir e bei f yra 2 ir 4 arba atitinkamai 4 ir 2 (lt)
C&L Inventory
tetranatrium-(c-(3-(1-(3-(e-6-dichloor-5-cyanopyrimidine-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatofenylsulfamoyl)ftalocyanine-a,b,d-trisulfonato(6-))nikkelaat II, waar a is 1 of 2 of 3 of 4,b is 8 of 9 of 10 of 11, c is 15 of 16 of 17 of 18,d is 22 of 23 of 24 of 25 en waar e en f respectief 2 en 4 of 4 en 2 zijn (nl)
C&L Inventory
tetranatrium-(c-(3-(1-(3-(e-6-dichlor-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phtalocyanin-a,b,d-trisulfonat(6-))nikkel (II), hvor a er 1 eller 2 eller 3 eller 4,b er 8 eller 9 eller 10 eller 11,c er 15 eller 16 eller 17 eller 18, d er 22 eller 23 eller 24 eller 25 og hvor e og f er enten 2 og 4 eller 4 og 2 (da)
C&L Inventory
Tetranatrium-(c-(3-(1-(3-(e-6-dichlor-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanin-a,b,d-trisulfonato(6-))nickelat (II) (a: 1,2,3 oder 4, b: 8,9,10 oder 11, c: 15,16,17 oder 18, d: 22,23,24 oder 25, e,f = 2 oder 4) (de)
C&L Inventory
Tetranatrium-(c-(3-(1-(3-(e-6-dikloori-5-syanopyrimidiini-f-yyli(metyyli)amino)propyyli)-1,6-dihydro-2-hydroksi-4-metyyli-6-oksi-3-pyridyyliatso)-4-sulfonaattifenyylisulfamoyyli)ftalosyaniini-a,b,d-trisulfonaatto(6-))nikkelaatti II, missä a on 1 tai 2 tai 3 tai 4, b on 8 tai 9 tai 10 tai 11, c on 15 tai 16 tai 17 tai 18, d on 22 tai 23 tai 24 tai 25 ja missä e ja f yhdessä ovat ja 2 ja 4 tai 4 ja 2 (fi)
C&L Inventory
tetranatrium-(c-(3-(1-(3-(e-6-diklor-5-cyanopyrimidin-f-yl(metyl)amino)propyl)-1,6-dihydro-2-hydroksy-4-metyl-6-okso-3-pyridylazo)-4-sulfonatofenylsulfamoyl)ftalocyanin-a,b,d-trisulfonato(6-))nikkelato(II), der a = 1, 2, 3 eller 4, b = 8, 9, 10 eller 11, c = 15, 16, 17 eller 18, d = 22, 23, 24 eller 25 og e og f enten = 2 og 4 eller 4 og 2 (no)
C&L Inventory
tetranatrium-(c-(3-(1-(3-(e-6-dikloro-5-cyanopyrimidin-f-yl(metyl)amino)propyl)-1,6-dihydro-2-hydroxi-4-metyl-6-oxo-3-pyridylazo)-4-sulfonatofenylsulfamoyl)ftalocyanin-a,b,d-trisulfonato(6-))nickelat (II),där = 1,2,3 eller 4, b = 8,9,10 eller 11, c = 15,16,17 eller 18, d = 22,23,24 eller 25 och där e och f tillsammans är 2 och 4 eller 4 och 2 respektive (sv)
C&L Inventory
tetranátrium-[c-[3-[1-[3-[e-6-diklór-5-cianopirimidin-f-il(metil)amino]propil]-1,6-dihidro-2-hidroxi-4-metil-6-oxo-3-piridilazo]-4-szulfonátofenilszulfamoil]ftalocianin-a,b,d-triszulfonáto(6-)]-nikkel II, ahol a=1 vagy 2 vagy 3 vagy 4, b=8 vagy 9 vagy 10 vagy 11, c=15 vagy 16 vagy 17 vagy 18, d=22 vagy 23 vagy 24 vagy 25 és ahol e és f =2 és 4 vagy 4 és 2 (hu)
C&L Inventory
tetranātrija (c-(3-(1-(3-(e-6-dihlor-5-cianopirimidīn-f-il (metil)amino)propil)-1,6-dihidro-2-hidroksi-4-metil-6-okso-3-piridilazo)-4-sulfonatofenilsulfamoil)ftalocianīn-a,b,d-trisulfonato(6-))niķelāts (II), kur attiecīgi a ir 1 vai 2, vai 3, vai 4, b ir 8 vai 9, vai 10, vai 11, c ir 15 vai 16, vai 17, vai 18, d ir 22 vai 23, vai 24, vai 25 un kur e un f kopā ir 2 un 4 vai 4 un 2 (lv)
C&L Inventory
tetrasodiu (c-(3-(1-(3-(e-6-diclor-5-cianopirimidin-f-il(metil)amino)propil)-1,6-dihidro-2-hidroxi-4-metil-6-oxo-3-piridilazo)-4-sulfonatofenilsulfamoil)ftalocianin-a,b,d-trisulfonato(6-))nichelato II, unde a este 1 sau 2 sau 3 sau 4,b este 8 sau 9 sau10 sau 11,c este 15 sau 16 sau 17 sau 18, d este 22 sau 23 sau 2sau 25 si unde e si f impreuna au 2 si 4 sau 4 si 2 respectiv (ro)
C&L Inventory
{c-[3-(1-{3-[e,6-dichloro-5-cyjano-pirymidyn-f-ylo(metylo)amino]propylo}--2-hydroksy-4-metylo-6-okso-1,6-dihydro--3-pirydylazo)-4-sulfonianofenylosulfa-moilo]ftalocyjanino-a,b,d-trisulfoniano(6-)}niklan(II) tetrasodu, gdzie: a = 1, 2, 3 lub 4; b = 8, 9, 10 lub 11; c = 15, 16, 17 lub 18; d = 22, 23, 24 lub 25; e i f są odpowiednio 2 i 4 lub 4 i 2 (pl)
C&L Inventory
Тетранатриев-(c-(3-(1-(3-(e-6-дихлоро-5-цианопиримидин-f-ил(метил)aмино)пропил)-1,6-дихидро-2-хидрокси-4-метил-6-oксо-3-пиридилазо)-4-сулфонатофенилсулфамоил)фталоцианин-a,b,d-трисулфонато(6-))никелато(II), където а е 1 или 2 или 3 или 4, b е 8 или 9 или 10 или 11, c е 15 или 16 или 17 или 18, d е 22 или 23 или 24 или 25 и f заедно са 2 и 4 или 4 и 2 съответно (bg)
C&L Inventory
Nickelate(4-), [C-[[[3-[[1-[3-[[2,6(or 4,6)-dichloro-5-cyano-4(or 2)-pyrimidinyl]methylamino]propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl]azo]-4-sulfophenyl]amino]sulfonyl]-29H,31H-phthalocyanine-C,C,C-trisulfonato(6-)-.kappa.N29,.kappa.N30,.kappa.N31,.kappa.N32]-, tetrasodium
Other
Brilliant Green K-RWa 6083
C&L Inventory
nickel(2+) tetrasodium 33-({3-[(E)-2-(1-{3-[(4,6-dichloro-5-cyanopyrimidin-2-yl)(methyl)amino]propyl}-2-hydroxy-4-methyl-6-oxo-1,6-dihydropyridin-3-yl)diazen-1-yl]-4-sulfophenyl}sulfamoyl)-2,11,20,29,37,38,39,40-octaazanonacyclo[28.6.1.1^{3,10}.1^{12,19}.1^{21,28}.0^{4,9}.0^{13,18}.0^{22,27}.0^{31,36}]tetraconta-1(36),2,4(9),5,7,10(40),11,13(18),14,16,19,21(38),22(27),23,25,28,30,32,34-nonadecaene-37,39-diide-7,15,24-trisulfonate
Other
148732-74-5
CAS number
C&L Inventory, Registration dossier, Other, CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, End-of-Life Vehicles Directive - Hazardous Substances, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, Medical Devices Regulation - Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties, Physical, Biological and Chemical Agents & Processes and Work
607-288-00-2
Index number
C&L Inventory

Scientific properties

Physical and chemical properties

This section provides physicochemical information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Appearance/physical state / colour

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Melting/freezing point

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Boiling point

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Density

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Vapour pressure

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Partition coefficient

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Water solubility

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Solubility in organic solvents / fat solubility

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Surface tension

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Flash point

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Auto flammability

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Flammability

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Explosiveness

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidising

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidation reduction potential

Data not provided by the registrant

pH

Data not provided by the registrant

Dissociation constant

Data not provided by the registrant

Viscosity

Data not provided by the registrant

Environmental fate and pathways

This section provides environmental fate and pathways information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Phototransformation in air

Data not provided by the registrant

Hydrolysis

Study results
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Phototransformation in water

Data not provided by the registrant

Phototransformation in soil

Data not provided by the registrant

Biodegradation in water - screening tests

Study results
  • 3 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 3
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Biodegradation in water & sediment - simulation tests

Data not provided by the registrant

Biodegradation in soil

Data not provided by the registrant

Bioaccumulation: aquatic / sediment

Data not provided by the registrant

Bioaccumulation: terrestrial

Data not provided by the registrant

Adsorption/desorption

Data not provided by the registrant

Henrys law constant (H)

Data not provided by the registrant

Distribution modelling

Data not provided by the registrant

Ecotoxicological information

This section provides ecotoxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Predicted No-Effect Concentration (PNEC)

Data not provided by the registrant

Short–term toxicity to fish

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Long–term toxicity to fish

Data not provided by the registrant

Short–term toxicity to aquatic invertebrates

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Long–term toxicity to aquatic invertebrates

Data not provided by the registrant

Toxicity to aquatic algae and cyanobacteria

Data not provided by the registrant

Toxicity to aquatic plants other than algae

Data not provided by the registrant

Toxicity to microorganisms

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Sediment toxicity

Data not provided by the registrant

Endocrine disrupter testing in aquatic vertebrates – in vivo

Data not provided by the registrant

Toxicity to terrestrial macroorganisms except arthropods

Data not provided by the registrant

Toxicity to terrestrial arthropods

Data not provided by the registrant

Toxicity to terrestrial plants

Data not provided by the registrant

Toxicity to soil microorganisms

Data not provided by the registrant

Toxicity to birds

Data not provided by the registrant

Toxicity to mammals

Data not provided by the registrant

Toxicological information

This section provides toxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Derived No- or Minimal Effect Level (DN(M)EL)

Data not provided by the registrant

Toxicokinetics, metabolism, and distribution

Data not provided by the registrant

Acute toxicity

Study results
oral
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
oral
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
inhalation
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
dermal
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

dermal
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
other routes
  • 0 studies submitted
  • 0 studies processed

No data available

other routes
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Irritation / corrosion

Study results
Study data: skin
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Study data: eye
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: eye
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Sensitisation

Study results
Study data: skin
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Study data: respiratory
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: respiratory
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Repeated dose toxicity

Study results
Study data: oral
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Study data: oral
Studies with data
Key study
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
Study data: inhalation
  • 0 studies submitted
  • 0 studies processed

No data available

Study data: inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Study data: dermal
  • 0 studies submitted
  • 0 studies processed

No data available

Study data: dermal
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Genetic toxicity

Study results
Study data: in vitro
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: in vitro
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Study data: in vivo
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: in vivo
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Carcinogenicity

Data not provided by the registrant

Toxicity to reproduction

Data not provided by the registrant

Neurotoxicity

Data not provided by the registrant

Immunotoxicity

Data not provided by the registrant

Endocrine disrupter mammalian screening - in vivo

Data not provided by the registrant